Search results
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 6 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 5 days ago'Far more benefit than harm' It is widely accepted that the AZ vaccine - and other COVID jabs -...
Salem CVS fined $75,000 for vaccine, drug violations in 2021, 2022
Roanoke Times· 5 hours agoA teenager received a COVID-19 vaccine that amounted to six doses as once, according to state...
3 No-Brainer Stocks to Buy With $500 Right Now
Motley Fool via Yahoo Finance· 14 hours agoOver the last two years, one of Wall Street's largest drug developers became a victim of its own success. During the COVID-19 pandemic, Pfizer was one of...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga· 2 days agoPfizer Inc PFE is looking to build on the success of its COVID-19 vaccine rollout by introducing a...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 1 day agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
The WHO’s naive global vaccine plan won’t withstand contact with reality
The Telegraph via Yahoo News· 6 days agoThe AstraZeneca vaccine was, for a while, the most celebrated product in Britain. The UK was one of...
AstraZeneca pulls its COVID-19 vaccine from the European market
Stamford Advocate· 7 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
Fortune· 7 days agoAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine